Rotator Cuff TearNCT01767740
Pilot Study of the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff
A study testing ULTRABRAID PLUS SUTURE and ULTRABRAID SUTURE in people with Rotator Cuff Tear, run by Smith & Nephew, Inc. at 4 sites in Canada.
Trial summary
The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Rotator Cuff Tear
- What is being tested?
- ULTRABRAID PLUS SUTURE and ULTRABRAID SUTURE
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 82 participants
- Where
- 4 sitesCanada
- Study dates
- Feb 2013to Nov 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Inclusion Criteria (Subjects must meet ALL of the following criteria):
- Male or female, aged 18 to 70 years at the time of surgery
- Willing and able to give voluntary informed consent to participate in this investigation
- Small (<1cm), Medium (1-3cm) or large (>3-5cm) tear of the supraspinatus tendon, which may or may not include the infraspinatus tendon of the rotator cuff. Tear size will be based on area of longest dimension as evidenced by clinical examination and diagnostic imaging prior to surgery, with the definitive measurement confirmed at surgery
- Tear requires repair within two years of initial diagnosis
- Tear must be anatomically repairable (must be able to get tendon back to the medial position on the footprint and at least back to the tuberosity)
- Willing and able, in the opinion of the Investigator, to cooperate with study procedures, and willing to return to study site for physical therapy and all post-operative study visits
Exclusion Criteria (Subjects must not meet ANY of the following criteria):
- Tears involving tendons other than the supraspinatus and infraspinatus
- Partial thickness tears of the rotator cuff (tear must be full thickness)
- Evidence of acute trauma including fracture or dislocation of the shoulder joint
- Chronic retraction
- Evidence of active infection, osteomyelitis, sepsis or distant infection which could spread to the index joint
- Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder
- Subject has had acromioplasty or diagnostic arthroscopy on the operative shoulder within one (1) year prior to scheduled surgery date
- Evidence of osteomalacia or other metabolic bone disorder(s) which may impair bone or soft tissue function
- Evidence of other significant shoulder pathology including (Type II-IV lesion, Bankart lesion, Hill Sachs lesion)
- Patient has grade 4 changes to articular cartilage in operative shoulder
- Inflammatory arthropathies
- Significant muscle paralysis of the shoulder girdle.
- Painful pathologies of the cervical spine
- Comminuted bone surface, which would compromise secure anchor fixation.
- Subject has a known sensitivity to implant materials, including sodium butyrate.
- Non-surgical rotator cuff associated treatment, such as corticosteroid injection, within one (1) month prior to scheduled surgery date
- Participating in another investigational trial or ongoing study that would interfere with the assessment of the primary and secondary outcomes
- Female patient who is pregnant, nursing, or of childbearing potential while not practicing effective contraceptive methods
- Currently known to abuse drugs or alcohol which could affect follow-up care or treatment outcomes
- Current smoker
- Major psychiatric illness, developmental handicap or inability to read and understand the English language
- Major medical illness that would preclude undergoing surgery
- Known to be involved in any active injury litigation claims relating to the study shoulder
- Unwilling or unable to be assessed according to study protocol for one year following surgery
- Patient requires a concomitant SLAP repair procedure in operative shoulder
- Surgeon plans to use transosseous sutures in the study procedure
- Surgeon plans to use a Platelet Rich Plasma product or another therapy intended to augment healing of the rotator cuff in the study procedure
- Protocol specified surgical technique cannot be followed for this subject
- Rotator cuff repair will be done via open (as opposed to arthroscopic) procedure
- Any other reason (in the judgment of the investigator)
Trial locations and contacts
4 sites in 1 country.
Canada4 sites
Innovation Science and Medicine
Burlington, Ontario, L7R 4C7
Fowler Kennedy Sport Medicine Clinic
London, Ontario, N6A 3K7
St. Josephs Hospital
London, Ontario, N6A 4L6
Women's College Hospital
Toronto, Ontario, M5C 1R6
About this study
Official title: Two-Arm, Single Blind, Randomized Pilot Study on the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff
The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair.
Read the detailed description
The primary objective of this two-arm, randomized, single-blind pilot study is to obtain safety data on the use of the ULTRABRAID Plus Suture and to assess the preliminary effectiveness of the use of the ULTRABRAID Plus Suture in comparison to the ULTRABRAID Suture in subjects undergoing rotator cuff repair. The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.
Secondary endpoints include:
rotator cuff integrity at the other time points, as well as between arms (1, 3, 6 weeks and 3, 12 months); difference in tissue thickness and muscle atrophy using high-resolution ultrasound between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); difference in tendon echogenicity and vascularity using Doppler ultrasound between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); difference in Constant Shoulder Assessment score and Western Ontario Rotator Cuff (WORC) Index between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); rehabilitation:
- time to active-assisted rehab exercises
- time to isometric rehab exercises
- time to discontinuation of an arm sling lab results (C-Reactive Protein [CRP], Erythrocyte Sedimentation Rate [ESR] and Butyric Acid Levels) at 1, 3, and 6 weeks postoperatively; adverse event (AE) rates (all categories).
- Conditions
- Rotator Cuff Tear
- Being tested
- ULTRABRAID PLUS SUTURE, ULTRABRAID SUTURE
- Keywords
- Rotator Cuff Tear, Supraspinatus Tear
- Medical subject headings
- Rotator Cuff Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ULTRABRAID PLUS SUTUREDevice
Rotator Cuff Repair with ULTRABRAID PLUS SUTURE
ULTRABRAID SUTUREDevice
Rotator Cuff Repair with ULTRABRAID SUTURE
| Study group | Role | What they receive |
|---|---|---|
| ULTRABRAID PLUS SUTURE | Experimental | ULTRABRAID Plus Suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair. Receives: Device: ULTRABRAID PLUS SUTURE |
| ULTRABRAID SUTURE | Active comparator | ULTRABRAID Suture is a marketed suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair. Receives: Device: ULTRABRAID SUTURE |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rotator Cuff Integrity
The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.
Measured: 6 months post-operatively
Secondary outcomes (8)
Rotator Cuff Integrity
To assess rotator cuff integrity defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.
Measured: 1, 3 and 6 weeks and 3 and 12 months post-operatively
Change in post-surgery tissue thickness, rotator cuff integrity, tendon echogenicity and muscle atrophy
Compared to Baseline (preop)
Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Vascularity
Compared to Baseline (preop)
Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Constant Shoulder Assessment
Compared to Baseline (preop)
Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Western Ontario Rotator Cuff Index
Compared to Baseline (preop)
Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Rehabilitation
- Time to active-assisted rehab exercises
- Time to isometric rehab exercises
- Time to discontinuation of arm sling
Measured: 3 and 6 weeks and 3, 6 and 12 months post-operatively
Labs
Compared to Baseline (preop) Note: If levels do not return to baseline, tests will continue beyond 6 weeks
Measured: 1, 3 and 6 weeks (optional 3, 6 and 12 months) post-operatively
Adverse Events
All AE measured and observed, from the initiation of the surgical procedure and throughout the subjects participation in the study, were recorded.
Measured: Surgery and 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2013 (estimated)
- Study startFeb 2013
- Primary completionNov 2016
- Study completionNov 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Rotator Cuff TearStudies of the same condition, open and under way.
- More trials run by Smith & Nephew, Inc.The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 82 participants (actual)
Sponsor and investigators
- Lead sponsor
- Smith & Nephew, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Robert Litchfield, MD, FRCSC, Principal investigator, Fowler Kennedy Sports Medicine Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01767740
- Sponsor's protocol ID
- 15001105
- Status last verified
- Oct 2017
- First submitted
- 9 Jan 2013
- Last updated
- 6 Oct 2017
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Two-Arm, Single Blind, Randomized Pilot Study on the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff
- ClinicalTrials.gov ID
- NCT01767740
- Acronym / sponsor ID
- 15001105
- Conditions
- Rotator Cuff Tear
- Keywords
- Rotator Cuff Tear, Supraspinatus Tear
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 82 participants (actual)
- Lead sponsor
- Smith & Nephew, Inc.Industry (pharma, biotech, devices)
- Study start
- Feb 2013
- Primary completion
- Nov 2016 (actual)
- Study completion
- Nov 2016 (actual)
- First posted
- 14 Jan 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair.
Detailed description
The primary objective of this two-arm, randomized, single-blind pilot study is to obtain safety data on the use of the ULTRABRAID Plus Suture and to assess the preliminary effectiveness of the use of the ULTRABRAID Plus Suture in comparison to the ULTRABRAID Suture in subjects undergoing rotator cuff repair. The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.
Secondary endpoints include:
rotator cuff integrity at the other time points, as well as between arms (1, 3, 6 weeks and 3, 12 months); difference in tissue thickness and muscle atrophy using high-resolution ultrasound between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); difference in tendon echogenicity and vascularity using Doppler ultrasound between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); difference in Constant Shoulder Assessment score and Western Ontario Rotator Cuff (WORC) Index between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); rehabilitation:
- time to active-assisted rehab exercises
- time to isometric rehab exercises
- time to discontinuation of an arm sling lab results (C-Reactive Protein [CRP], Erythrocyte Sedimentation Rate [ESR] and Butyric Acid Levels) at 1, 3, and 6 weeks postoperatively; adverse event (AE) rates (all categories).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ULTRABRAID PLUS SUTURE | Experimental | Device: ULTRABRAID PLUS SUTUREULTRABRAID Plus Suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair. |
| ULTRABRAID SUTURE | Active comparator | Device: ULTRABRAID SUTUREULTRABRAID Suture is a marketed suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair. |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ULTRABRAID PLUS SUTURERotator Cuff Repair with ULTRABRAID PLUS SUTURE | Device | ULTRABRAID PLUS SUTURE |
| ULTRABRAID SUTURERotator Cuff Repair with ULTRABRAID SUTURE | Device | ULTRABRAID SUTURE |
Primary outcome
Rotator Cuff Integrity
Time frame: 6 months post-operatively
The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.
8 secondary outcomes
Rotator Cuff Integrity
Time frame: 1, 3 and 6 weeks and 3 and 12 months post-operatively
Change in post-surgery tissue thickness, rotator cuff integrity, tendon echogenicity and muscle atrophy
Time frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Vascularity
Time frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Constant Shoulder Assessment
Time frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Change in Western Ontario Rotator Cuff Index
Time frame: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Rehabilitation
Time frame: 3 and 6 weeks and 3, 6 and 12 months post-operatively
Labs
Time frame: 1, 3 and 6 weeks (optional 3, 6 and 12 months) post-operatively
Adverse Events
Time frame: Surgery and 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2017.
Related trials for Rotator Cuff Tear
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Active, not recruitingPhase 1
E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults
Rotator Cuff Tears, Muscle Atrophy or Weakness
Not yet recruiting
Voll Non-Degradable Shoulder Spacer FIH Study
Massive Rotator Cuff Tears, Massive Rotator Cuff Tear
Active, not recruitingPhase 2
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
Orthopedics, Traumatology
Recruiting
SMR Stemless Reverse vs SMR Reverse Shoulder System
Arthroplasty, Replacement
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Robert Litchfield, MD, FRCSC principal investigator
Fowler Kennedy Sports Medicine Clinic
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ULTRABRAID PLUS SUTURE and ULTRABRAID SUTURE in people with Rotator Cuff Tear, run by Smith & Nephew, Inc. at 4 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rotator Cuff Integrity (time frame: 6 months post-operatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2017.